Lantus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Metformin and Glimepiride (Low Dosage);   Drug: Metformin and Vildagliptin (Low Dosage);   Drug: Metformin and Insulin Glargine U100 (Low Dosage);   Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage);   Drug: Metformin and Glimepiride (Regular  Dosage);   Drug: Metformin and Vildagliptin (Regular Dosage);   Drug: Metformin and Insulin Glargine U100 (Regular Dosage);   Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage) Sponsor:   University of Jordan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2020 Category: Research Source Type: clinical trials

PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus ® in Type 1 Diabetes Mellitus Patients
Condition:   Diabetes Mellitus, Type 1 Intervention:   Drug: Gan & Lee Insulin Glargine Injection Sponsor:   Gan and Lee Pharmaceuticals, USA Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2020 Category: Research Source Type: clinical trials